For Research Purposes Only

gastrointestinal

BPC-157 for Stomach Ulcers

Animal studies show promise

How It Works

Promotes angiogenesis, increases growth factor expression, and has cytoprotective effects.

Research Evidence

Multiple animal studies demonstrate efficacy. Human data is anecdotal but extensive.

Dosing Protocol

250-500mcg daily, subcutaneously or orally (stable arginine salt), for 4-8 weeks.

Important Considerations

  • !No human clinical trials
  • !WADA banned
  • !Gray market quality concerns
  • !Consult healthcare provider before use
  • !Quality sourcing is critical

Frequently Asked Questions

Does BPC-157 work for stomach ulcers?

Multiple animal studies demonstrate efficacy. Human data is anecdotal but extensive. Research level: Animal studies show promise.

How does BPC-157 help with stomach ulcers?

Promotes angiogenesis, increases growth factor expression, and has cytoprotective effects.

What is the BPC-157 dosage for stomach ulcers?

250-500mcg daily, subcutaneously or orally (stable arginine salt), for 4-8 weeks.

Is BPC-157 safe for stomach ulcers?

Key considerations: No human clinical trials. WADA banned. Gray market quality concerns. Consult healthcare provider before use. Quality sourcing is critical. Always consult a healthcare provider.

How long until BPC-157 works for stomach ulcers?

Results vary by individual and condition severity. Most users report initial effects within 2-4 weeks, with full benefits developing over 8-12 weeks of consistent use.

Learn More

Disclaimer: This information is for educational and research purposes only. BPC-157 is not FDA approved for this use. Consult qualified healthcare professionals.